AntalGenics

About:

AntalGenics is a biotechnology company that develops active molecules for biomedical and dermatological applications.

Top Investors: Inveready, Centre for the Development of Industrial Technology (CDTI)

Description:

AntalGenics develops in the field of sensory neurobiology for pharmaceutical and dermocosmetic applications. They provide services in customized research and development, sensory neurobiology, molecular modeling, and throughput screening. The company's aim is to translate scientific discoveries into products and services.

Total Funding Amount:

808000 EUR

Headquarters Location:

Alicante, Comunidad Valenciana, Spain

Founded Date:

2015-01-01

Contact Email:

info(AT)antalgenics.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-02-11

IPO Status:

Private

Industries: